Denouel, Angéline
Brandel, Jean-Philippe
Seilhean, Danielle
Laplanche, Jean-Louis
Elbaz, Alexis
Haik, Stéphane
Funding for this research was provided by:
Institut de Veille Sanitaire (Institut de Veille Sanitaire)
Article History
Received: 31 January 2023
Accepted: 6 April 2023
First Online: 16 May 2023
Declarations
:
: AE reports grants from Agence nationale de recherche (ANR), Michael J Fox foundation, Plan Ecophyto (French ministry of agriculture), and France Parkinson, outside the submitted work. SH has received research support from Institut de Recherche Servier, LFB Biomedicaments and MedDay Pharmaceuticals outside the scope of this study. SH has a patent method for treating prion diseases (PCT/EP 2019/070457) pending and filed two patents (EP 21 305 659 and EP 21 305 660) on the use of specific compounds to treat prion diseases. The other authors report no disclosures.